118 related articles for article (PubMed ID: 2892379)
1. HSV-1 infection and immunity in immunosuppressed mice.
Litwińska B; Sadowski W; Kańtoch M
Acta Virol; 1987 Aug; 31(4):298-306. PubMed ID: 2892379
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
Rager-Zisman B; Allison AC
J Immunol; 1976 Jan; 116(1):35-40. PubMed ID: 173758
[TBL] [Abstract][Full Text] [Related]
3. Immunological studies of hsv-infection of resistant and susceptible inbred strains of mice.
Kirschner H; Kochen M; Hirt HM; Munk K
Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):147-54. PubMed ID: 645175
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
Kutinová L; Vonka V; Slichtová V
Acta Virol; 1980 Dec; 24(6):391-8. PubMed ID: 6111199
[TBL] [Abstract][Full Text] [Related]
5. Autologous antibody is protective against HSV-1 infection of the immunocompromised mouse.
Alexander TS; Rosenthal KS
J Lab Clin Med; 1990 Sep; 116(3):400-7. PubMed ID: 2169516
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of herpes simplex virus (type 2) infection in trigeminal ganglia and oral lips with cyclophosphamide treatment.
Kurata T; Kurata K; Aoyama Y
Jpn J Exp Med; 1978 Oct; 48(5):427-35. PubMed ID: 219274
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression of mice by cyclophosphamide (CyP) and cyclosporin A (CsA) changes the course of HSV-1 infection and the distribution of viral DNA in target organs.
Berkowitz-Balshayi C; Rösen-Wolff A; Darai G; Becker Y
In Vivo; 1995; 9(2):155-62. PubMed ID: 7548792
[TBL] [Abstract][Full Text] [Related]
8. Infections of susceptible and resistant mouse strains with herpes simplex virus type 1 and 2.
Caspary L; Schindling B; Dundarov S; Falke D
Arch Virol; 1980; 65(3-4):219-27. PubMed ID: 6251783
[TBL] [Abstract][Full Text] [Related]
9. Experimental Escherichia coli 06 infection in mice. II. Protective factors of immunity after immunosuppression.
Ahlstedt S
Scand J Infect Dis Suppl; 1980; Suppl 24():216-9. PubMed ID: 7010558
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus latency in immunosuppressed mice.
Rotula A; Di Luca D; Gerna G; Manservigi R; Tognon M; Cassai E
Microbiologica; 1984 Jul; 7(3):219-27. PubMed ID: 6094985
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of lymphatic and hematologic spreading as a pathogenic condition for neural persistence of herpes simplex virus].
Gerritzen A; Schneweis KE
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):559-69. PubMed ID: 2837877
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
[TBL] [Abstract][Full Text] [Related]
13. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice.
Habu S; Akamatsu K; Tamaoki N; Okumura K
J Immunol; 1984 Nov; 133(5):2743-7. PubMed ID: 6207244
[TBL] [Abstract][Full Text] [Related]
14. Vertical transmission of type 2 herpes simplex virus infection in immunosuppressed hamsters.
Kurata T; Kurata K; Aoyama Y
Jpn J Exp Med; 1978 Oct; 48(5):437-43. PubMed ID: 219275
[TBL] [Abstract][Full Text] [Related]
15. Role of NK cells in protection of mice against herpes simplex virus-1 infection.
Rager-Zisman B; Quan PC; Rosner M; Moller JR; Bloom BR
J Immunol; 1987 Feb; 138(3):884-8. PubMed ID: 3805719
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of immunity to herpes simplex virus by in vivo administration of interleukin 2.
Rouse BT; Miller LS; Turtinen L; Moore RN
J Immunol; 1985 Feb; 134(2):926-30. PubMed ID: 2981270
[TBL] [Abstract][Full Text] [Related]
17. Stress causes a further decrease in immunity to herpes simplex virus-1 in immunocompromised hosts.
Cao L; Martin A; Polakos N; Moynihan JA
J Neuroimmunol; 2004 Nov; 156(1-2):21-30. PubMed ID: 15465593
[TBL] [Abstract][Full Text] [Related]
18. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
19. Protective immunization of mice with specific HSV-1 glycoproteins.
Chan WL
Immunology; 1983 Jun; 49(2):343-52. PubMed ID: 6303950
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies of experimental pathogenesis of herpes simplex virus in mice. Intracerebral, Intraperitoneal and oral infection of the suckling mice].
Rajcáni J; Sabo A; Blaskovic D
Zentralbl Bakteriol Orig; 1969; 211(4):421-36. PubMed ID: 4195419
[No Abstract] [Full Text] [Related]
[Next] [New Search]
